Mylan, Apotex Secure FDA Approval For Generic Boniva
The U.S. Food and Drug Administration on Monday approved the first generic versions of the popular osteoporosis drug Boniva, opening the door to generic-drug makers Mylan Pharmaceuticals Inc., Apotex Inc. and Orchid Healthcare...To view the full article, register now.
Already a subscriber? Click here to view full article